Lazard Asset Management’s Alexion Pharmaceuticals ALXN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-21,267	Closed	-$3.91M	–	2358
2021 Q2	$3.91M	Buy	21,267 +594	+3%	+$102K	﹤0.01%	755
2021 Q1	$3.16M	Buy	20,673 +7,312	+55%	+$1.13M	﹤0.01%	727
2020 Q4	$2.09M	Sell	13,361 -184	-1%	-$23.6K	﹤0.01%	790
2020 Q3	$1.55M	Sell	13,545 -207	-2%	-$22.3K	﹤0.01%	759
2020 Q2	$1.54M	Sell	13,752 -16,066	-54%	-$1.71M	﹤0.01%	713
2020 Q1	$2.68M	Buy	29,818 +10,899	+58%	+$1.07M	﹤0.01%	623
2019 Q4	$2.04M	Buy	18,919 +17,643	+1,383%	+$1.89M	﹤0.01%	670
2019 Q3	$124K	Sell	1,276 -12	-0.9%	-$1.35K	﹤0.01%	968
2019 Q2	$168K	Buy	1,288 +1,276	+10,633%	+$164K	﹤0.01%	1050
2019 Q1	$1K	Hold	12	–	–	﹤0.01%	1137
2018 Q4	$1K	Hold	12	–	–	﹤0.01%	1016
2018 Q3	$1K	Hold	12	–	–	﹤0.01%	1043
2018 Q2	$1K	Hold	12	–	–	﹤0.01%	1022
2018 Q1	$1K	Sell	12 -44	-79%	-$5.26K	﹤0.01%	1031
2017 Q4	$6K	Buy	56 +33	+143%	+$4.02K	﹤0.01%	1005
2017 Q3	$3K	Buy	23 +11	+92%	+$1.49K	﹤0.01%	955
2017 Q2	$1K	Hold	12	–	–	﹤0.01%	1003
2017 Q1	$1K	Hold	12	–	–	﹤0.01%	1007
2016 Q4	$1K	Hold	12	–	–	﹤0.01%	986
2016 Q3	$1K	Hold	12	–	–	﹤0.01%	982
2016 Q2	$1K	Buy	12 +6	+100%	+$851	﹤0.01%	1030
2016 Q1	$0	Hold	6	–	–	﹤0.01%	1135
2015 Q4	$1K	Buy	+6	New	+$1.05K	﹤0.01%	1094
2014 Q2	–	Sell	-1,200	Closed	-$182K	–	1082
2014 Q1	$182K	Buy	+1,200	New	+$191K	﹤0.01%	832

Other funds holding ALXN